The impact of timing of temozolomide chemoradiotherapy for newly diagnosed glioblastoma on patient overall survival: A multicenter retrospective study.
Lau ACK, Chan BLH, Yeung CSK, Li LF, Chan DTM, Lee MWY, Chan TKT, Ho JMK, Cheung KM, Tse TPK, Lau SSN, Chow JSW, Ko NMW, Loong HHF, El-Helali A, Poon WS, Woo PYM.
Lau ACK, et al. Among authors: tse tpk.
Neurooncol Adv. 2024 Nov 12;6(1):vdae194. doi: 10.1093/noajnl/vdae194. eCollection 2024 Jan-Dec.
Neurooncol Adv. 2024.
PMID: 39659837
Free PMC article.